New IBD treatment research from Northeastern points to a potato-derived peptide that may ease Crohn’s and ulcerative colitis symptoms.
Targeting the gut microbiome with fecal microbiota transplantation (FMT) may help cancer patients with immunotherapy-related ...
Leading biotech stock Abivax (ABVX) jumped Monday on compelling test results for its experimental ulcerative colitis treatment. The company tested its drug, obefazimod, in patients with ulcerative ...
Researchers at The University of Texas MD Anderson Cancer Center have identified a previously unknown role for B cells, which ...
“The rapid symptom control provided by upadacitinib and infliximab may be particularly advantageous for patients with a high symptom burden where quick improvement is the priority, particularly in ...
Emerging therapies for ulcerative colitis treatment, such as Obefazimod (Abivax), Tulisokibart (Merck), Olamkicept (Ferring Pharmaceuticals), Afimkibart (Roche), Icotrokinra (Johnson & ...
New research reveals a gap between support for earlier advanced therapy and real-world prescribing in Japan, with many ...
A new drug for treating a type of inflammatory bowel disease (IBD) has been given the go-ahead by the Food and Drug Administration. On Friday, the FDA approved Pfizer’s etrasimod, branded as Velsipity ...
Ulcerative Colitis Market grows at 5.4% CAGR (2025–2033), reaching US$ 12.79 Billion on rising biologic adoption, biosimilars, and personalized IBD therapies. North America leads the ulcerative ...
In a striking illustration of how far the reach of inflammatory bowel disease can extend beyond the gut, clinicians have ...
Colitis and ulcerative colitis (UC) can look very similar because they share symptoms like abdominal pain, diarrhea, and bloody stool, and they both involve inflammation of the colon (the large ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results